Sakura Finetek

Torrance, United States Founded: 1986 • Age: 40 yrs
Manufactures histology and pathology equipment for medical laboratories and diagnostics.

About Sakura Finetek

Sakura Finetek is a company based in Torrance (United States) founded in 1986 by Takashi Tsuzuki. It operates as a B2B. Sakura Finetek has completed 1 acquisition, including Genemed Biotechnologies. Sakura Finetek offers products and services including Tissue-Tek Accu-Edge Grossing Stations, Microtome Blades, Reagents, and Staining Systems. Sakura Finetek operates in a competitive market with competitors including Evosep, Ovizio, Pressure BioSciences, Curiox and inveox, among others.

Key Metrics
  • Annual Revenue
    ₹9.55 Cr

    FY 2025 · +25% YoY

  • Net Profit
    ₹56.1 Lakh

    FY 2025 · 6% margin

  • EBITDA
    ₹1.29 Cr

    FY 2025 · 14% margin

  • Investments & Acquisitions

Products & Services of Sakura Finetek

Sakura Finetek offers a comprehensive portfolio of products and services, including Tissue-Tek Accu-Edge Grossing Stations, Microtome Blades, Reagents, and Staining Systems.

Tissue-Tek Accu-Edge Grossing Stations
Grossing Equipment

Tools for preparing tissue samples in pathology labs.

Microtome Blades
Cutting Tools

Blades for precise sectioning of tissue specimens.

Reagents
Chemical Supplies

Substances used for tissue processing and staining.

Staining Systems
Diagnostic Instruments

Automated systems for slide staining in histology.

Apps and channels of Sakura Finetek

its YouTube channel Sakura Finetek USA has 1.46K subscribers and 30 videos.

Sakura Finetek USA
YouTube 1.46K subscribers 30 videos Science & Technology
Open channel

Videos from Sakura Finetek

The most watched videos on Sakura Finetek's YouTube channel, Sakura Finetek USA (1.46K subscribers). Click a video to play it here.

Tissue-Tek AutoSection® Automated Microtomy Solution
5.8K views
CLIA Regulation Fundamentals and Recent Updates
5.3K views
Laboratory Safety Part 1 Chemical Safety and General Lab Safety
4.1K views
Tissue Tek Film Coverslipper Replacing Coverslipping Film
3.6K views

More on Sakura Finetek USA.

Board of directors of Sakura Healthcare Private Limited (Sakura Finetek)

Sakura Healthcare Private Limited is the primary company behind Sakura Finetek. The board of Sakura Healthcare Private Limited currently have 3 directors; the longest-serving is Abhishek Kapoor, appointed in 2018.

DirectorDesignationAppointedTenureEntity
Abhishek Kapoor
DIN 07065549
Director20 Dec 20187 yrs 9 moSakura Healthcare Private Limited
Jolly Joan Jesse Benjamin
DIN 08297091
Director20 Dec 20187 yrs 9 moSakura Healthcare Private Limited
Kamlesh Kumar Sah
DIN 08515387
Director19 Jul 20197 yrs 2 moSakura Healthcare Private Limited

People of Sakura Finetek

41 people are tracked at Sakura Finetek (8 in leadership, 33 in team).

NameRoleGroup
Takashi Tsuzuki
Founder, CEOLeadership
Yashi Osaka
Sr. Director, Infection Prevention & Sterilization Business DevelopmentLeadership
Kam Patel
President and Chief Operating OfficerLeadership
Erico von Bueren
Sr. Director Of Marketing And StrategyLeadership
Tina Locke
Director Of Customer Operations And Contract ManagementLeadership
Joseph Castille
Senior Vice President OperationsLeadership
Rina Wu Decamillis
Vice President Of Sakura BioscienceLeadership
Scott Webster
Vice President Of R&dLeadership
Angela R.
Area Sales ManagerTeam
Jeff Depinto Jr.
Area Sales Manager IITeam
Molly Forman
Area Sales ManagerTeam
Jason Lela
Area Sales ManagerTeam
Thomas Kokkines
Area Sales ManagerTeam
Kate Coldren
Area Sales ManagerTeam
Michael Gunderson
Area Sales Manager IITeam
Susan Campbell
Area Sales ManagerTeam
Aimee Ray
Area Sales ManagerTeam
Brian Fingleton
Western Regional ManagerTeam
Amit Shah
Senior R&d Sciences ManagerTeam
Boris Alonso
Senior Contract AdministratorTeam

21 more people are available in the full profile.

Premium access

Complete people profiles for Sakura Finetek

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Sakura Finetek

Figures of Sakura Healthcare Private Limited, the primary company behind Sakura Finetek, for FY 2025. Revenue was ₹9.55 Cr (+25% year on year). Net profit was ₹56.1 Lakh (6% margin). EBITDA was ₹1.29 Cr (14% margin). Revenue has grown at a compounded annual rate of +1% over three years and +25% over five years.

  • ₹9.55 CrRevenue · FY 2025 · +25% YoY
  • ₹56.1 LakhNet profit · 6% margin
  • ₹1.29 CrEBITDA · 14% margin
  • ₹1 LakhPaid-up capital
  • +1%Revenue CAGR, 3 years
  • +25%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Sakura Healthcare Private Limited are on its company page.

Premium access

Detailed financial statements for Sakura Finetek

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Sakura Finetek

Sakura Finetek has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Genemed Biotechnologies.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
IVD reagents for diagnostics are manufactured and marketed globally.
genemed.comSan Francisco, United States1987Jan 2016••••
Premium access

Complete acquisition details for Sakura Finetek

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Sakura Finetek

2 dated milestones of Sakura Finetek across 30 years, from founding to its latest funding, stage changes and deals.

  1. Founded Sakura Finetek is founded.
  2. Acquisition Acquires Genemed Biotechnologies.

Competitors of Sakura Finetek

Sakura Finetek operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evosep, Ovizio, Pressure BioSciences, Curiox and inveox, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
evosep.com2016Odense, Denmark$48.78M62
Solutions for clinical proteomics sample preparation are developed.
ovizio.com2009Brussels, Belgium$9.1M16
Imaging systems and AI software for microscopes are developed.
pressurebiosciences.com1978Easton, United States–15
Biomolecular reactions are controlled via pressure cycling technology.
curiox.com2007Singapore$30M–
Wall-less plates and washers are developed for automated cell-based assays.
inveox.com2017Munich, Germany$25.81M–
Automated solutions for biopsy sample preparation in laboratories are provided.
annaida.ch2018Lausanne, Switzerland$1.06M–
Magnetic resonance sensors for microscopic studies are developed.
acousort.com2010Lund, Sweden$213,996–
Microfluidic acoustofluidics technology for cell separation is developed.
inso.bio2020Ithaca, United States$2.45M–
Microfluidic automated devices for cellular sample preparation are developed.
qinstruments.com2003Jena, Germany–27
Robotic instruments for sample preparation are developed by QInstruments.
Premium access

Detailed competitors of Sakura Finetek

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Sakura Finetek

The website of Sakura Finetek (sakuraus.com) receives about 17.8K visits a month.

  • Monthly visits
    17.8K

    ▲ 24.6% vs previous month

Similar websites

Websites whose visitors overlap most with Sakura Finetek. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
cellpath.com
97%
9.8K#2,384,735View details
mopec.com
96%
18.2K#1,493,355View details
conmed.com
78%
76.6K#441,510View details

Latest news on Sakura Finetek

Premium access

Complete news archive for Sakura Finetek

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Sakura Finetek

10 companies that operate in the same segment as Sakura Finetek (Traditional Diagnostics & Medical Devices), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Materials management solutions are provided for healthcare organizations.
1892Chicago, Illinois, United StatesUSD 29.13 MUSD 20.63 B53,000
3D-printed orthopedic products are manufactured for medical applications.
1941Kalamazoo, Michigan, United States–––
Ophthalmic pharmaceuticals and instruments are developed for eye care.
1853Bridgewater, New Jersey, United States–USD 5.1 B13,500
Heart pumps are developed for blood circulation and oxygenation support.
1981Danvers, Massachusetts, United States–USD 1.03 B1,157
Medical device management services are provided to healthcare facilities.
1999Exeter, New Hampshire, United StatesUSD 275.93 MUSD 68.67 M353
Medical surgical consumables including sutures and anti-microbial gloves are manufactured.
1992Bengaluru, Karnataka, IndiaUSD 102.36 MUSD 7.14 K39
Manufacturer of medical equipments
1967Bengaluru, Karnataka, IndiaUSD 58.9 MUSD 98.65 M578
BD is recognized for providing innovative medical technology solutions.
1897Franklin Lakes, New Jersey, United States–USD 21.84 B74,000
Dental lasers and scanning devices are developed for clinical use.
1987Foothill Ranch, California, United States–USD 49.16 M–
Manufacturer and distributor of aprons, surgical gowns, uniforms, and other medical products
1966Mundelein, Illinois, United States–USD 28.45 B1,305
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Sakura Finetek

Sakura Finetek was founded in 1986.

Sakura Finetek is headquartered in Torrance, United States. It is registered at Torrance, California, United States.

Takashi Tsuzuki is the current CEO of Sakura Finetek. They have also founded this company.

The primary company behind Sakura Finetek, Sakura Healthcare Private Limited, reported revenue of ₹9.55 Cr for FY 2025, up 25% year on year.

Sakura Finetek USA, Inc. develops and supplies innovative tools for anatomic pathology, including grossing stations, microtomes, reagents, and staining systems. They focus on improving efficiency in tissue processing and diagnostics through advanced technology. Based in the Americas, the company serves laboratories and medical facilities globally, emphasizing quality and customer support in histopathology workflows.

Sakura Finetek's top competitors include Ovizio, Curiox and Evosep.

Sakura Finetek offers Tissue-Tek Accu-Edge Grossing Stations, Microtome Blades, Reagents, and Staining Systems.

Sakura Finetek has made 1 acquisition, including Genemed Biotechnologies.

Sakura Finetek operates through Sakura Healthcare Private Limited.

The legal entities of Sakura Finetek currently have 3 directors, including Abhishek Kapoor, Jolly Joan Jesse Benjamin, Kamlesh Kumar Sah.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available